Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

INTERPARFUMS INC Regulatory Filings 2009

Nov 9, 2009

31321_rns_2009-11-09_3f379ca3-1a46-4e87-b46e-ac753b90d4f6.zip

Regulatory Filings

Open in viewer

Opens in your device viewer

8-K 1 v165380_8k.htm Unassociated Document Licensed to: Vintage Filings Document Created using EDGARizer 4.0.6.4 Copyright 1995 - 2008 EDGARfilings, Ltd., an IEC company. All rights reserved

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported):

November 9, 2009

Inter Parfums , Inc.

(Exact name of registrant as specified in its charter)

Delaware (State or other jurisdiction of incorporation or organization) 0-16469 Commission File Number 13-3275609 (I.R.S. Employer Identification No.)

551 Fifth Avenue, New York, New York 10176

(Address of Principal Executive Offices)

  1. 983.2640

(Registrant's Telephone number, including area code)


(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions (see General Instruction A.2 below):

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting Material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 2.02. Results of Operations and Financial Condition.

Certain portions of our press release dated November 9, 2009, a copy of which is annexed hereto as Exhibit no. 99.1, are incorporated by reference herein and are filed pursuant to this Item 2.02. They are as follows:

· The 1 st through 7 th paragraphs all relating to income and expense for the third quarter and the nine months ended September 30, 2009

· The 12 th paragraph relating to the conference call to be held on November 10, 2009

· The consolidated statements of income and consolidated balance sheets.

Item 7.01. Regulation FD Disclosure .

Certain portions of our press release dated November 9, 2009, a copy of which is annexed hereto as Exhibit no. 99.1, are incorporated by reference herein, and are filed pursuant to this Item 7.01 and Regulation FD. They are as follows:

· The 8 th paragraph relating to proposed product launches and rollouts for European opeations

· The 9 th paragraph relating to United States opeations

· The 10 th paragraph relating to 2009 guidance

· The 14 th paragraph relating to forward looking information.

· The balance of such press release not otherwise incorporated by reference in Item 2.02 or Item 8.01

Item 8.01. Other Events.

The 11 th paragraph of our press release dated November 9, 2009 relating to payment of quarterly dividends is incorporated by reference herein.

Item 9.01 Financial Statements and Exhibits.

99.1 Our press release dated November 9, 2009.

SIGNATURES

Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused and authorized this report to be signed on its behalf by the undersigned.

| /s/ Russell
Greenberg |
| --- |
| Russell
Greenberg, Executive
Vice President and Chief Financial
Officer |